期刊文献+

原发性胆汁性胆管炎伴抑郁小鼠的肝肠损伤及肠黏膜中ZO-1的表达变化

Hepatointestinal injury and changes of ZO-1 expression in intestinal mucosa of mice with primary biliary cholangitis and depression
下载PDF
导出
摘要 目的研究原发性胆汁性胆管炎(primary biliary cholangitis,PBC)伴抑郁小鼠的肝肠损伤及肠黏膜中闭锁小带蛋白1(zonula occludens protein 1,ZO-1)的表达变化。方法选取24只6周龄雌性C57BL/6小鼠,随机分为对照组、PBC组、PBC+抑郁组、PBC+抑郁+腹腔注射氯米帕明组,每组6只,根据不同实验组模型要求造模:抑郁模型小鼠采用慢性不可预知的轻度刺激方式处理,PBC组小鼠给予含0.1%3,5-二乙氧基羰基-1,4-二氢-2,4,6-三甲基吡啶(3,5-diethyloxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine,DDC)饲料喂养,PBC+抑郁+腹腔注射氯米帕明组小鼠每日同一时间腹腔内注射氯米帕明7.5mg/kg以诱导模型。小鼠完成造模后测量小鼠体质量分析造模情况。处死并同时采集肝组织及肠组织标本,苏木精-伊红(hematoxylin and eosin,HE)染色观察各组肝及肠组织的显微病理变化。应用免疫组织化学染色技术检测各组小鼠肠组织中ZO-1的表达水平。结果与对照组比较,各模型组小鼠的体质量均明显下降(P<0.05),PBC+抑郁组小鼠的体质量较PBC组小鼠降低(P<0.05),PBC+抑郁+腹腔注射氯米帕明组小鼠的体质量较PBC+抑郁组小鼠显著增高(P<0.05)。与对照组比较,各模型组小鼠的肝组织损伤严重,且出现不同程度的肠组织病理损伤,ZO-1在各模型组小鼠肠黏膜中的表达水平均显著下降(P<0.01);与PBC组比较,PBC+抑郁组小鼠的肠黏膜中ZO-1表达水平显著降低(P<0.01);与PBC+抑郁组比较,PBC+抑郁+腹腔注射氯米帕明组小鼠的肠黏膜中ZO-1表达水平显著升高(P<0.01)。结论抗抑郁治疗可显著改善PBC伴抑郁小鼠的肝肠损伤及肠黏膜中ZO-1的表达。 Objective To explore the hepatointestinal injury and changes of zonula occludens protein 1(ZO-1)expression in intestinal mucosa of mice with primary biliary cholangitis(PBC)and depression.Methods A total of 24 six-week-old female C57BL/6 mice were randomly divided into control group,PBC group,PBC+depression group,PBC+depression+intraperitoneal injection of clomipramine group,6 mice in each group.The models were made according to the requirements of different experimental groups.The depression model was treated with chronic unpredictable mild stimulation.PBC group was fed with feed containing 0.1%3,5-diethyloxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine(DDC).In the intraperitoneal injection group,7.5 mg/kg of clomipramine was injected intraperitoneally at the same time every day to induce the model.The body weight of the mice was measured to analyze the establishment of the model.The mice were sacrificed and liver and intestinal tissue samples were collected at the same time.Observation of histopathological changes of liver and intestinal tissues in each group by hematoxylin and eosin(HE)staining.Immunohistochemical staining was used to detect the expression level of ZO-1 in intestinal tissues of each group.Results Compared with control group,the body weight of the mice in each model group decreased significantly(P<0.05),and the body weight of PBC+depression group was lower than that of PBC group(P<0.05).The body weight of PBC+depression+intraperitoneal injection of clomipramine group was significantly higher than that of PBC+depression group(P<0.05).Compared with control group,the liver tissue of each model group was seriously injured,and there were pathological injuries of intestinal tissue with different severity.Compared with control group,the expression level of ZO-1 in the intestinal mucosa of each model group was significantly decreased(P<0.01).Compared with PBC group,the expression level of ZO-1 in PBC+depression group was significantly decreased(P<0.01).Compared with PBC+depression group,the expression level of ZO-1 in PBC+depression+intraperitoneal injection of clomipramine group was significantly increased(P<0.01).Conclusion Antidepressant treatment can significantly improve the hepatointestinal injury and the expression of ZO-1 in the intestinal mucosa of PBC with depression in mice.
作者 张紫阳 王晶 ZHANG Ziyang;WANG Jing(Graduate School of Baotou Medical College,Baotou 014040,Inner Mongolia,China;Department of Gastroenterology,the Second Affiliated Hospital of Baotou Medical College,Inner Mongolia University of Science&Technology,Baotou 014031,Inner Mongolia,China)
出处 《中国现代医生》 2023年第33期8-12,共5页 China Modern Doctor
基金 内蒙古自治区自然科学基金项目(2020MS08080)。
关键词 原发性胆汁性胆管炎 肠道黏膜屏障 闭锁小带蛋白1 肠–脑轴 动物实验 Primary biliary cholangitis Intestinal mucosal barrier ZO-1 Intestinal-brain axis Animal experiment
  • 相关文献

参考文献14

二级参考文献107

  • 1张绘宇,张雅洁.非小细胞肺癌生物学特性免疫组化图像定量分析[J].中国体视学与图像分析,2006,11(2):77-79. 被引量:7
  • 2Bonnavion P,de Lecea L.Hypocretins in the control of sleep and wakefulness[J].Curr Neurol Neurosci Rep,2010,10(3):174-179.
  • 3Fenzl T,Romanowski CP,Flachskamm C,et al.Wake-promoting effects of orexin: Its independent actions against the background of an impaired corticotropine-releasing hormone receptor system[J].Behav Brain Res,2011,222(1):43-50.
  • 4Feng P,Hu Y,Li D,et al.The effect of clomipramine on wake/ sleep and orexinergic expression in rats [J].J Psychopharmacol,2009,23(5):559-566.
  • 5Wilson S,Argyropoulos S.Antidepressants and sleep: a qualitative review of the literature[J].Drugs,2005,65(7):927-947.
  • 6Hoque R,Chesson AL.Pharmacologically induced/exacerbated restless legs syndrome,periodic limb movements of sleep,and REM behavior disorder/REM sleep without atonia: literature review,qualitative scoring,and comparative analysis[J].J Clin Sleep Med,2010,6(1):79-83.
  • 7Mayers AG,Baldwin DS.Antidepressants and their effect on sleep[J].Hum Psychopharmacol,2005,20(8):533-559.
  • 8Sakurai T,Mieda M,Tsujino N.The orexin system: roles in sleep/ wake regulation[J].Ann N Y Acad Sci,2010,1200:149-161.
  • 9Haj-Dahmane S,Shen RY.The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling[J].J Neurosci,2005,25(4):896905.
  • 10Wang C J,Zhou Z G,Holmqvist A,et al.Survivin expression quantified by Image Pro-Plus compared with visual assessment[J]. Appl Immunohistochem Mol Morphol, 2009,17 (6):530-535.

共引文献326

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部